Literature DB >> 23685996

Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls.

M Boyadzhieva1, I Atanasova, S Zacharieva, S Kedikova.   

Abstract

BACKGROUND: This study aims to explore the changes in maternal serum adipocytokines during pregnancy and post partum in normal and complicated with gestational diabetes (GDM) pregnancies and to investigate the relationship between serum adipocytokines and some of major metabolic parameters.
MATERIALS AND METHODS: 236 pregnant women (127 with GDM and 109 control group) and 50 postpartum women (30 with GDM during pregnancy and 20 controls). Using ELISA and EIA kits, serum levels of adipocytokines were tested during pregnancy and post partum. Maternal adipocytokines levels were correlated with some metabolic parameters.
RESULTS: Women with GDM had lower values of adiponectin and higher values of leptin during pregnancy (p<0.001; 0.0001) and post partum (p<0.002; 0.0001). Serum apelin was significantly lower in GDM group (p<0.009). However, we did not find significance for resistin (p<0.317) and apelin (p<0.218). Positive correlation for leptin and negative for adiponectin was found for pre-pregnancy and pregnancy body mass index, glycated hemoglobin and homeostasis model assessment of insulin resistance index. Using cut point of 8.2 μg/ml for adiponectin and 28.7 ng/ml for leptin could exclude GDM with a sensitivity of 83.6%/81.2% and specificity of 56.6%/64.2% (area under the curve 0.702 and 0.827).
CONCLUSION: There are constant differences in adiponectin and leptin levels between GDM and control group during pregnancy and post partum. Apelin was decreased in our GDM group and no differences were found for resistin and visfatin. Further studies are required to verify the mechanism of this alteration and whether the adipocytokines can be predictors for GDM at an early stage of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685996     DOI: 10.3275/8968

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  37 in total

Review 1.  The effects of adipose tissue and adipocytokines in human pregnancy.

Authors:  G Valsamakis; S Kumar; G Creatsas; G Mastorakos
Journal:  Ann N Y Acad Sci       Date:  2010-09       Impact factor: 5.691

Review 2.  Adiponectin--an adipokine with unique metabolic properties.

Authors:  Andrzej Wiecek; Marcin Adamczak; Jerzy Chudek
Journal:  Nephrol Dial Transplant       Date:  2007-01-18       Impact factor: 5.992

3.  Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus.

Authors:  Po-Jung Tsai; Chun-Hsien Yu; Shih-Penn Hsu; Yu-Hsiang Lee; I-Tsan Huang; Su-Chen Ho; Chun-Hong Chu
Journal:  Nutrition       Date:  2005 Nov-Dec       Impact factor: 4.008

4.  Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy.

Authors:  Kylie A McLachlan; David O'Neal; Alicia Jenkins; Frank P Alford
Journal:  Diabetes Metab Res Rev       Date:  2006 Mar-Apr       Impact factor: 4.876

5.  [Relationship of serum levels of adiponectin, leptin, tumor necrosis factor-alpha and c-reactive protein with insulin resistance during first trimester pregnancy].

Authors:  Tao Liu; Qing Liu; Dong Yang; Zhen Fang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2011-04-19

6.  Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes.

Authors:  Renata Saucedo; Arturo Zarate; Lourdes Basurto; Marcelino Hernandez; Edgardo Puello; Rosa Galvan; Sandra Campos
Journal:  Arch Med Res       Date:  2011-05       Impact factor: 2.235

7.  Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies.

Authors:  Nikolaos Vitoratos; Aikaterini Deliveliotou; Alexandra Dimitrakaki; Dimitrios Hassiakos; Constantinos Panoulis; Efthimios Deligeoroglou; George K Creatsas
Journal:  J Obstet Gynaecol Res       Date:  2010-12-16       Impact factor: 1.730

8.  Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies.

Authors:  Donatella Cortelazzi; Sabrina Corbetta; Stefania Ronzoni; Francesca Pelle; Annamaria Marconi; Veronica Cozzi; Irene Cetin; Riccardo Cortelazzi; Paolo Beck-Peccoz; Anna Spada
Journal:  Clin Endocrinol (Oxf)       Date:  2007-03       Impact factor: 3.478

9.  Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition.

Authors:  Ana Megia; Joan Vendrell; Cristina Gutierrez; Modest Sabaté; Montse Broch; José-Manuel Fernández-Real; Inmaculada Simón
Journal:  Eur J Endocrinol       Date:  2008-02       Impact factor: 6.664

Review 10.  The current biology of resistin.

Authors:  Claire M Steppan; Mitchell A Lazar
Journal:  J Intern Med       Date:  2004-04       Impact factor: 8.989

View more
  8 in total

1.  Osteocalcin, under-carboxylated osteocalcin and osteopontin are not associated with gestational diabetes mellitus but are inversely associated with leptin in non-diabetic women.

Authors:  R Saucedo; G Rico; G Vega; L Basurto; L Cordova; R Galvan; M Hernandez; E Puello; A Zarate
Journal:  J Endocrinol Invest       Date:  2014-12-06       Impact factor: 4.256

2.  Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle.

Authors:  Ha T Tran; Stella Liong; Ratana Lim; Gillian Barker; Martha Lappas
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

3.  Maternal serum level of resistin is associated with risk for gestational diabetes mellitus: A meta-analysis.

Authors:  Shi-Min Hu; Meng-Shi Chen; Hong-Zhuan Tan
Journal:  World J Clin Cases       Date:  2019-03-06       Impact factor: 1.337

4.  Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Jianran Sun; Jiale Ren; Chunlin Zuo; Datong Deng; Faming Pan; Ruoping Chen; Jie Zhu; Chao Chen; Shandong Ye
Journal:  Lipids Health Dis       Date:  2020-02-22       Impact factor: 3.876

Review 5.  The Role of the Adipokines in the Most Common Gestational Complications.

Authors:  Paweł Gutaj; Rafał Sibiak; Maurycy Jankowski; Karina Awdi; Rut Bryl; Paul Mozdziak; Bartosz Kempisty; Ewa Wender-Ozegowska
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 6.  Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus.

Authors:  Monika Ruszała; Magdalena Niebrzydowska; Aleksandra Pilszyk; Żaneta Kimber-Trojnar; Marcin Trojnar; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

7.  The Potential Role of Chemerin, Lipocalin 2, and Apelin in the Diagnosis and Pathophysiology of Gestational Diabetes Mellitus.

Authors:  Radzisław Mierzyński; Elżbieta Poniedziałek-Czajkowska; Dominik Dłuski; Maciej Kamiński; Agnieszka Mierzyńska; Bożena Leszczyńska-Gorzelak
Journal:  J Diabetes Res       Date:  2021-06-09       Impact factor: 4.011

Review 8.  Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases.

Authors:  A Lorenzo-Almorós; T Hang; C Peiró; L Soriano-Guillén; J Egido; J Tuñón; Ó Lorenzo
Journal:  Cardiovasc Diabetol       Date:  2019-10-30       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.